| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.40B | +3.5% |
| Cost of Revenue | $16.50B | +3.1% |
| Gross Profit | $963.0M | — |
| R&D Expense | $1.13B | +2.9% |
| SG&A Expense | $1.67B | +14.2% |
| Operating Income | $1.18B | -35.7% |
| Interest Expense | $361.0M | +7.1% |
| Pre-tax Income | $919.0M | -57.3% |
| Income Tax | $700.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.85B | +17.7% |
| Accounts Receivable | $3.48B | +6.6% |
| Inventory | $2.56B | +10.4% |
| Current Assets | $8.74B | +11.7% |
| Total Assets | $23.41B | -0.2% |
| Current Liabilities | $5.04B | -1.8% |
| Long-term Debt | $7.65B | -9.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.19B | -10.7% |
| Investing Cash Flow | -$498.0M | +1.8% |
| Financing Cash Flow | -$1.44B | +26.6% |
| +213.9% |
| Net Income | $165.0M | -90.8% |
| EPS (Basic) | $0.75 | -89.2% |
| EPS (Diluted) | $0.75 | -89.2% |
| Total Liabilities |
| $13.91B |
| -3.2% |
| Stockholders' Equity | $9.21B | +4.7% |